Get started
Author

Mateusz M. Wydro

GRSF1 Regulates RNA Processing in Mitochondrial RNA Granules
2013 · Alexis A. Jourdain, Mirko Koppen, et al. · Cell Metabolism · 242
PDF
Optimization of transient Agrobacterium-mediated gene expression system in leaves of Nicotiana benthamiana.
2006 · Mateusz Wydro, Edward Kozubek, et al. · Acta Biochimica Polonica · 242
PDF
Human mitochondrial mRNAs—like members of all families, similar but different
2010 · Richard J. Temperley, Mateusz Wydro, et al. · Biochimica et Biophysica Acta (BBA) - Bioenergetics · 232
PDF
mtRF1a Is a Human Mitochondrial Translation Release Factor Decoding the Major Termination Codons UAA and UAG
2007 · Hamid Reza Soleimanpour-Lichaei, Inge Kühl, et al. · Molecular Cell · 142
PDF
Human ERAL1 is a mitochondrial RNA chaperone involved in the assembly of the 28S small mitochondrial ribosomal subunit
2010 · Sven Dennerlein, Agata Rozanska, et al. · Biochemical Journal · 135
PDF
The human mitochondrial ribosome recycling factor is essential for cell viability
2008 · Joanna Rorbach, Ricarda Richter, et al. · Nucleic Acids Research · 120
PDF
FS118, a Bispecific Antibody Targeting LAG-3 and PD-L1, Enhances T-Cell Activation Resulting in Potent Antitumor Activity
2020 · Matthew Kraman, Mustapha Faroudi, et al. · Clinical Cancer Research · 113
Injury and differentiation following inhibition of mitochondrial respiratory chain complex IV in rat oligodendrocytes
2010 · Iryna Ziabreva, Graham Campbell, et al. · Glia · 103
PDF
The Evolutionarily Conserved Iron-Sulfur Protein INDH Is Required for Complex I Assembly and Mitochondrial Translation in Arabidopsis
2013 · Mateusz M. Wydro, Pia Sharma, et al. · The Plant Cell · 74
PDF
Targeting of the cytosolic poly(A) binding protein PABPC1 to mitochondria causes mitochondrial translation inhibition
2010 · Mateusz Wydro, Agnieszka Bobrowicz, et al. · Nucleic Acids Research · 57
PDF
A HER2-specific Modified Fc Fragment (Fcab) Induces Antitumor Effects Through Degradation of HER2 and Apoptosis
2015 · Kin-Mei Leung, Sarah Batey, et al. · Molecular Therapy · 36
PDF
Probing the orientation of yeast VDAC1 in vivo
2009 · Beth M. McDonald, Mateusz M. Wydro, et al. · FEBS Letters · 32
PDF
Abstract 2719: Dual blockade of PD-L1 and LAG-3 with FS118, a unique bispecific antibody, induces CD8+ T-cell activation and modulates the tumor microenvironment to promote antitumor immune responses
2018 · Matthew Kraman, Natalie Fosh, et al. · Cancer Research · 14
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one
2016 · Andreas Lundqvist, Vincent van Hoef, et al. · Journal for ImmunoTherapy of Cancer · 12
PDF
Insights into the pathogenic character of a commonNUBPLbranch-site mutation associated with mitochondrial disease and complex I deficiency using a yeast model
2013 · Mateusz M. Wydro, Janneke Balk · Disease Models & Mechanisms · 12
Abstract PR06: A LAG-3/PD-L1 bispecific antibody inhibits tumour growth in two syngeneic colon carcinoma models
2017 · Katy Everett, Matthew Kraman, et al. · Cancer Immunology Research · 3
Abstract 2399: LAG-3/PD-L1 mAb2 can overcome PD-L1-mediated compensatory upregulation of LAG-3 induced by single-agent checkpoint blockade
2019 · Mustapha Faroudi, Matthew Kraman, et al. · Cancer Research · 2
Abstract 4547: Clustering CD137 via cell-expressed PD-L1 crosslinking avoided Fc-mediated agonism and resulted in safe and potent conditional lymphocyte activation
2020 · Matthew A. Lakins, Alexander Koers, et al. · Cancer Research · 1
Abstract 1540: FS222 mAb2, a bispecific conditional agonist antibody targeting CD137 and PD-L1, induces potent lymphocyte activation and has a favorable safety profile
2019 · Matthew A. Lakins, Alexander Koers, et al. · Immunology · 1
Abstract 1540: FS222 mAb2, a bispecific conditional agonist antibody targeting CD137 and PD-L1, induces potent lymphocyte activation and has a favorable safety profile
2019 · Matthew A. Lakins, Alexander Koers, et al. · Cancer Research · 1
Abstract B091: A LAG-3/PD-L1 bispecific antibody inhibits tumor growth in two syngeneic colon carcinoma models
2016 · Jacqueline Doody, Matthew Kraman, et al. · Cancer Immunology Research · 1
Abstract B123: Preclinical evaluation of FS102: A HER2-specific Fcab with a novel mechanism of action.
2013 · Sarah Batey, Kinmei Leung, et al. · Molecular Cancer Therapeutics · 1
Kraman et al Supplementary Data from FS118, a Bispecific Antibody Targeting LAG-3 and PD-L1, Enhances T-Cell Activation Resulting in Potent Antitumor Activity
2023 · Matthew Kraman, Mustapha Faroudi, et al.
PDF
Data from FS118, a Bispecific Antibody Targeting LAG-3 and PD-L1, Enhances T-Cell Activation Resulting in Potent Antitumor Activity
2023 · Matthew Kraman, Mustapha Faroudi, et al.
Data from FS118, a Bispecific Antibody Targeting LAG-3 and PD-L1, Enhances T-Cell Activation Resulting in Potent Antitumor Activity
2023 · Matthew Kraman, Mustapha Faroudi, et al.
Works count: 33
Citation count: 1,576
H-index: 13
I10-index: 15
Year
Topic
Type